2025-04-08 18:28:41
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Titan Biotech posts Rs. 5.23 crore consolidated PAT in Q3FY22
Posted On : 2022-02-09 17:46:33( TIMEZONE : IST )
TITAN BIOTECH LTD. has reported Consolidated financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 36.1935 crores during the period ended December 31, 2021 as compared to Rs. 41.1118 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 5.2305 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 6.3923 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 6.33 for the period ended December 31, 2021 as compared to Rs. 7.74 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 36.1935 crs | ₹41.1118 crs |  -11.96% |
| Net Profit | ₹5.2305 crs | ₹6.3923 crs | -18.17% |
| EPS | ₹6.33 | ₹7.74 | -18.22% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 36.1935 crores during the period ended December 31, 2021 as compared to Rs.34.7334 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.5.2305 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.6.6248 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.6.33 for the period ended December 31, 2021 as compared to Rs.8.02 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 36.1935 crs | ₹34.7334 crs |  4.20% |
| Net Profit | ₹5.2305 crs | ₹6.6248 crs | -21.05% |
| EPS | ₹6.33 | ₹8.02 | -21.07% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.118.8885 crores during the 9 Months period ended December 31, 2021 as compared to Rs.107.2074 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.20.3460 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.26.5741 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.24.62 for the 9 Months period ended December 31, 2021 as compared to Rs.32.16 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹118.8885 crs | ₹107.2074 crs | 10.90% |
| Net Profit | ₹20.3460 crs | ₹26.5741 crs | -23.44% |
| EPS | ₹24.62 | ₹32.16 | -23.45% |
Shares of TITAN BIOTECH LTD. was last trading in BSE at Rs. 307.05 as compared to the previous close of Rs. 308.10. The total number of shares traded during the day was 8499 in over 349 trades.
The stock hit an intraday high of Rs. 312.00 and intraday low of 301.00. The net turnover during the day was Rs. 2597828.00.
